AT-406
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AT-406, covering 2013-01-23 to 2013-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML) [Phase 1]